MOSCOW—Gritman Medical Center recently purchased an advanced Wound Healing Center diagnostic tool, the LUNA, which uses fluorescence microangiography to assess blood circulation in chronic and acute wounds.
The only diagnostic tool of its kind in the region, the LUNA enables physicians to detect areas with inadequate blood flow before they develop into more serious issues. Early detection of blood flow loss can help prevent the amputation of limbs.
Using a small IV, patients are injected with a fluorescent agent (ICG). A 2.5 minute study is then recorded with still images and HD video. Theses images are interpreted by the Gritman medical director. If the results show a loss of blood flow, the patient may be referred to a vascular surgeon for further treatment.
ICG does not involve the potential safety hazards associated with traditional X-ray angiography and common contrast agents, making it an ideal technology for use by wound care staff.
“We can look at a foot and not see the underlying lack of oxygen that the LUNA can detect,” said Sharon Cofre, director of Gritman’s Wound Healing Center. “This provides valuable information for the vascular surgeon and can show the need for treatment earlier than before.”
The LUNA can also be used to measure the success of Hyperbaric Oxygen treatments, also offered in Gritman’s Wound Healing Center.
Gritman Medical Center is a non-profit, people-focused, community-driven organization that provides excellent and compassionate healthcare for the people of its communities. Gritman Medical Center has received national recognition for its leadership, patient satisfaction and customer service.
Fluorescence Angiography is similar to X-ray but does not involve the safety concerns of exposure to radiation and the potentially harmful contrast agents. LUNA procedures capitalize on the properties of a fluorescent agent called Indocyanine Green (ICG), which emits light when stimulated by a low-powered